Peptidic phosphinyloxymethyl ketones as interleukin-1.beta.-conv

Details Peptidic phosphinyloxymethyl ketones as interleukin-1.beta.-conv Peptidic phosphinyloxymethyl ketones as interleukin-1.beta.-conv

1996-02-06

1998-12-01

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 19, 530331, 544182, A61K 3806, A61K 3800, C07K 500, C07K 700

Patent

active

058439056

ABSTRACT:
Disclosed are compounds, compositions and methods for inhibiting interleukin -1.beta. protease activity, the compounds having the structure of formula (1) as described in the specification.

REFERENCES:
patent: 5055451 (1991-10-01), Krantz et al.
patent: 5462939 (1995-10-01), Dolle et al.
patent: 5585486 (1996-12-01), Dolle et al.

Affiliated with

Also associated with

Rating

Peptidic phosphinyloxymethyl ketones as interleukin-1.beta.-conv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptidic phosphinyloxymethyl ketones as interleukin-1.beta.-conv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidic phosphinyloxymethyl ketones as interleukin-1.beta.-conv will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2395687